(SYF) Synchrony Financial - Ratings and Ratios
Credit Cards, Installment Loans, Deposits, Healthcare Financing
SYF EPS (Earnings per Share)
SYF Revenue
Description: SYF Synchrony Financial October 14, 2025
Synchrony Financial (NYSE:SYF) is a U.S.-based consumer-finance company that originates and services a broad range of credit products-including private-label, co-branded, and general-purpose credit cards, as well as short- and long-term installment loans-through partnerships with retailers, manufacturers, and healthcare providers. In addition, the firm offers a suite of deposit products (e.g., CDs, IRAs, money-market and savings accounts) and accepts deposits via third-party brokerage channels.
Key operating segments include: (1) **Retail Credit**, where SYF issues private-label cards for partners such as American Eagle, Dick’s Sporting Goods, and CareCredit/Walgreens; (2) **Consumer Banking**, delivering deposit and savings solutions; and (3) **Healthcare Financing**, leveraging the CareCredit brand. The company’s revenue mix is heavily weighted toward interest income from its credit-card portfolio, which represented roughly 70 % of total net interest income in Q3 2024.
**Recent performance metrics (as of Q3 2024):**
- Net interest margin (NIM) stood at 7.1 % (down 0.3 % YoY, reflecting higher funding costs).
- Total loan portfolio reached $31.2 bn, up 5 % YoY, driven by growth in private-label credit cards.
- Deposit balances grew 4 % YoY to $12.5 bn, supported by competitive APY offerings on savings products.
- Return on equity (ROE) was 12.4 % (above the consumer-finance industry average of ~10 %).
**Macro-economic drivers:**
1. **Federal-Reserve policy** – Rising rates increase SYF’s net interest income but also pressure credit-card delinquency rates; the company’s delinquency ratio rose to 2.8 % in Q3 2024 (vs. 2.5 % a year earlier).
2. **Consumer spending trends** – Retail-partner sales growth directly boosts private-label card usage; a 3 % YoY increase in retail sales in Q2 2024 correlated with a 2 % rise in SYF’s card spend volume.
3. **Healthcare cost inflation** – The CareCredit segment benefits from higher out-of-pocket expenses, providing a defensive revenue stream when discretionary retail spending softens.
**Competitive landscape:** SYF competes with large banks (e.g., JPMorgan, Citibank) and fintech lenders that are expanding private-label card programs. Its niche focus on retailer-specific financing and a diversified deposit franchise give it a differentiated risk profile, but the firm remains exposed to credit-quality cycles and the broader consumer-credit environment.
For a deeper quantitative comparison of SYF’s valuation metrics against peers, the ValueRay platform offers a concise dashboard that can help surface any pricing anomalies.
SYF Stock Overview
| Market Cap in USD | 25,297m |
| Sub-Industry | Consumer Finance |
| IPO / Inception | 2014-07-31 |
SYF Stock Ratings
| Growth Rating | 73.4% |
| Fundamental | 74.3% |
| Dividend Rating | 56.4% |
| Return 12m vs S&P 500 | 15.3% |
| Analyst Rating | 4.05 of 5 |
SYF Dividends
| Dividend Yield 12m | 1.50% |
| Yield on Cost 5y | 4.61% |
| Annual Growth 5y | 3.25% |
| Payout Consistency | 99.5% |
| Payout Ratio | 9.9% |
SYF Growth Ratios
| Growth Correlation 3m | 15.2% |
| Growth Correlation 12m | 53.7% |
| Growth Correlation 5y | 53.5% |
| CAGR 5y | 31.26% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.83 |
| CAGR/Mean DD 3y (Pain Ratio) | 2.85 |
| Sharpe Ratio 12m | 0.64 |
| Alpha | 10.97 |
| Beta | 1.500 |
| Volatility | 32.66% |
| Current Volume | 2363k |
| Average Volume 20d | 3233.6k |
| Stop Loss | 70.3 (-4%) |
| Signal | 0.44 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (3.58b TTM) > 0 and > 6% of Revenue (6% = 966.4m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 0.45pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 148.9% (prev -282.0%; Δ 430.9pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 9.88b > Net Income 3.58b (YES >=105%, WARN >=100%) |
| Net Debt (-16.25b) to EBITDA (5.72b) ratio: -2.84 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.29 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (379.4m) change vs 12m ago -4.31% (target <= -2.0% for YES) |
| Gross Margin 32.33% (prev 47.36%; Δ -15.02pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 13.64% (prev 18.44%; Δ -4.80pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.03 (EBITDA TTM 5.72b / Interest Expense TTM 5.42b) >= 6 (WARN >= 3) |
Altman Z'' 2.58
| (A) 0.21 = (Total Current Assets 106.05b - Total Current Liabilities 82.06b) / Total Assets 116.98b |
| (B) 0.20 = Retained Earnings (Balance) 23.98b / Total Assets 116.98b |
| (C) 0.05 = EBIT TTM 5.60b / Avg Total Assets 118.11b |
| (D) 0.24 = Book Value of Equity 23.93b / Total Liabilities 99.92b |
| Total Rating: 2.58 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 74.30
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 40.29% = 5.0 |
| 3. FCF Margin 61.31% = 7.50 |
| 4. Debt/Equity 0.91 = 2.11 |
| 5. Debt/Ebitda -2.84 = 2.50 |
| 6. ROIC - WACC (= 2.19)% = 2.74 |
| 7. RoE 21.29% = 1.77 |
| 8. Rev. Trend -15.33% = -1.15 |
| 9. EPS Trend 86.60% = 4.33 |
What is the price of SYF shares?
Over the past week, the price has changed by +4.26%, over one month by -2.01%, over three months by +2.05% and over the past year by +35.59%.
Is Synchrony Financial a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SYF is around 76.17 USD . This means that SYF is currently overvalued and has a potential downside of 4%.
Is SYF a buy, sell or hold?
- Strong Buy: 9
- Buy: 5
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SYF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 82.5 | 12.7% |
| Analysts Target Price | 82.5 | 12.7% |
| ValueRay Target Price | 86.9 | 18.7% |
SYF Fundamental Data Overview October 18, 2025
P/E Trailing = 7.7029
P/E Forward = 7.8616
P/S = 2.6228
P/B = 1.6623
P/EG = 1.6071
Beta = 1.5
Revenue TTM = 16.11b USD
EBIT TTM = 5.60b USD
EBITDA TTM = 5.72b USD
Long Term Debt = 15.46b USD (from longTermDebt, last fiscal year)
Short Term Debt = 5.65b USD (from shortTermDebt, last fiscal year)
Debt = 15.46b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -16.25b USD (from netDebt column, last quarter)
Enterprise Value = 24.51b USD (25.30b + Debt 15.46b - CCE 16.25b)
Interest Coverage Ratio = 1.03 (Ebit TTM 5.60b / Interest Expense TTM 5.42b)
FCF Yield = 40.29% (FCF TTM 9.88b / Enterprise Value 24.51b)
FCF Margin = 61.31% (FCF TTM 9.88b / Revenue TTM 16.11b)
Net Margin = 22.20% (Net Income TTM 3.58b / Revenue TTM 16.11b)
Gross Margin = 32.33% ((Revenue TTM 16.11b - Cost of Revenue TTM 10.90b) / Revenue TTM)
Gross Margin QoQ = -341.7% (prev 53.08%)
Tobins Q-Ratio = 0.21 (Enterprise Value 24.51b / Total Assets 116.98b)
Interest Expense / Debt = 13.91% (Interest Expense 2.15b / Debt 15.46b)
Taxrate = 24.63% (352.0m / 1.43b)
NOPAT = 4.22b (EBIT 5.60b * (1 - 24.63%))
Current Ratio = 1.29 (Total Current Assets 106.05b / Total Current Liabilities 82.06b)
Debt / Equity = 0.91 (Debt 15.46b / totalStockholderEquity, last quarter 17.07b)
Debt / EBITDA = -2.84 (Net Debt -16.25b / EBITDA 5.72b)
Debt / FCF = -1.64 (Net Debt -16.25b / FCF TTM 9.88b)
Total Stockholder Equity = 16.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.06% (Net Income 3.58b / Total Assets 116.98b)
RoE = 21.29% (Net Income TTM 3.58b / Total Stockholder Equity 16.79b)
RoCE = 17.35% (EBIT 5.60b / Capital Employed (Equity 16.79b + L.T.Debt 15.46b))
RoIC = 13.33% (NOPAT 4.22b / Invested Capital 31.64b)
WACC = 11.14% (E(25.30b)/V(40.76b) * Re(11.54%) + D(15.46b)/V(40.76b) * Rd(13.91%) * (1-Tc(0.25)))
Discount Rate = 11.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.44%
[DCF Debug] Terminal Value 68.46% ; FCFE base≈9.74b ; Y1≈10.76b ; Y5≈13.93b
Fair Price DCF = 394.6 (DCF Value 142.09b / Shares Outstanding 360.1m; 5y FCF grow 12.02% → 3.0% )
EPS Correlation: 86.60 | EPS CAGR: 34.73% | SUE: 2.44 | # QB: 3
Revenue Correlation: -15.33 | Revenue CAGR: -39.49% | SUE: -0.63 | # QB: 0
Additional Sources for SYF Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle